Editage
Research Solutions English Editing AI Solutions Publication Support Journal Finder Corporate Solutions More

Cancer genetics

eISSN: 2210-7770pISSN: 2210-7762

Check your submission readiness

Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.

Key Metrics

CiteScore
3.8
H-Index
50
Impact Factor
< 5
SJR
Q3Genetics
SNIP
0.69
Time to Publish
time-to-publish View Chart
5  Mo

Journal Specifications

Overview
  • Publisher
    ELSEVIER SCIENCE INC
  • Language
    English
  • Frequency
    Bi-monthly
General Details
View less
Time to Publish
Time to publish distribution
Articles published in year 2022
Time to publish index
Months% Papers published
0-3 12%
4-6 50%
7-9 21%
>9 17%

Topics Covered

Cancer
Fusion gene
Lung cancer
Fluorescence in situ hybridization
Paroxysmal nocturnal hemoglobinuria
Late Recurrence
DNA repair
Glioblastoma
Conventional cytogenetics
Gene expression
Pheochromocytoma
Pediatric AML
Ataxia telangiectasia mutated
Hematopoietic stem cell transplantation
Colorectal cancer
Clinical significance
Germline
Karyotype
Diffuse large B-cell lymphoma
Overall survival

FAQs

Since when has Cancer genetics been publishing? Faqs

The Cancer genetics has been publishing since 2011 till date.

How frequently is the Cancer genetics published? Faqs

Cancer genetics is published Bi-monthly.

What is the H-index. SNIP score, Citescore and SJR of Cancer genetics? Faqs

Cancer genetics has a H-index score of 50, Citescore of 3.8, SNIP score of 0.69, & SJR of Q3

Who is the publisher of Cancer genetics? Faqs

The publisher of Cancer genetics is ELSEVIER SCIENCE INC.

How can I view the journal metrics of Cancer genetics on editage? Faqs

For the Cancer genetics metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Cancer genetics? Faqs

The eISSN number is 2210-7770 and pISSN number is 2210-7762 for Cancer genetics.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Cancer, Fusion gene, Lung cancer, Fluorescence in situ hybridization, Paroxysmal nocturnal hemoglobinuria, Late Recurrence, DNA repair, Glioblastoma, Conventional cytogenetics, Gene expression, Pheochromocytoma, Pediatric AML, Ataxia telangiectasia mutated, Hematopoietic stem cell transplantation, Colorectal cancer, Clinical significance, Germline, Karyotype, Diffuse large B-cell lymphoma, Overall survival.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.